LONDON BRIEFING: Wetherspoon swings to profit; UK house prices fall
(Alliance News) - Stocks in London are called to open higher on Friday, as investors eye a key nonfarm payroll reading in the US.
Read moreTue, 10th Mar 2015 11:53
(Alliance News) - Stocks in London are called to open higher on Friday, as investors eye a key nonfarm payroll reading in the US.
Read moreFriday 6 October | |
Admiral Group PLC | dividend payment date |
Alfa Financial Software Holdings PLC | special dividend payment date |
Anglo-Eastern Plantations PLC | dividend payment date |
Blackrock World Mining Trust PLC | dividend payment date |
Cairn Homes PLC | dividend payment date |
Dalata Hotel Group PLC | dividend payment date |
Drax Group PLC | dividend payment date |
Glanbia PLC | dividend payment date |
GlobalData PLC | dividend payment date |
Goodwin PLC | dividend payment date |
Greggs PLC | dividend payment date |
Intertek Group PLC | dividend payment date |
Irish Continental Group PLC | dividend payment date |
JPMorgan American Investment Trust PLC | dividend payment date |
JPMorgan Global Growth & Income PLC | dividend payment date |
Land Securities Group PLC | dividend payment date |
Personal Assets Trust PLC | dividend payment date |
Quartix Technologies PLC | dividend payment date |
Serco Group PLC | dividend payment date |
Walker Crips Group PLC | dividend payment date |
Warehouse REIT PLC | dividend payment date |
Zotefoams PLC | dividend payment date |
Monday 9 October | |
Henderson Smaller Cos Investment Trust PLC | dividend payment date |
LondonMetric Property PLC | dividend payment date |
Tuesday 10 October | |
LSL Property Services PLC | dividend payment date |
Wednesday 11 October | |
Assura PLC | dividend payment date |
Rathbones Group PLC | dividend payment date |
Thursday 12 October | |
Blackrock Latin American Investment Trust PLC | ex-dividend payment date |
Breedon Group PLC | ex-dividend payment date |
Diageo PLC | dividend payment date |
GSK PLC | dividend payment date |
Howden Joinery Group PLC | ex-dividend payment date |
i3 Energy PLC | ex-dividend payment date |
Invesco Bond Income Plus Ltd | ex-dividend payment date |
JPMorgan Asia Growth & Income PLC | ex-dividend payment date |
JPMorgan Mid Cap Investment Trust PLC | ex-dividend payment date |
Kingfisher PLC | ex-dividend payment date |
MP Evans Group PLC | ex-dividend payment date |
Macfarlane Group PLC | dividend payment date |
North American Income Trust PLC | ex-dividend payment date |
Oxford Instruments PLC | dividend payment date |
Persimmon PLC | ex-dividend payment date |
Personal Group Holdings PLC | ex-dividend payment date |
Primary Health Properties PLC | ex-dividend payment date |
Ruffer Investment Co Ltd | ex-dividend payment date |
Senior PLC | ex-dividend payment date |
Spirax-Sarco Engineering PLC | ex-dividend payment date |
Strategic Equity Capital PLC | ex-dividend payment date |
Supermarket Income REIT PLC | ex-dividend payment date |
Taylor Wimpey PLC | ex-dividend payment date |
Tesco PLC | ex-dividend payment date |
TT Electronics PLC | dividend payment date |
WPP PLC | ex-dividend payment date |
XP Power Ltd | dividend payment date |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |
GSK PLC - London-based pharmaceutical company - On Monday, announces that the UK Medicines & Health Products Regulatory Agency has authorised a new indication for Jemperli, also known as dostarlimab. The drug is used as a treatment for some types of endometrial cancer and an be used to treat patients that have a tumour abnormality called mismatch repair deficient/microsatellite instability-high when the cancer is at an advanced stage when first diagnosed or has returned after previous treatment. It is now authorised to be used together with chemotherapy to slow the progression of these cancers. GSK says it is the first medicine licensed as first line treatment for primary advanced or recurrent endometrial cancer.
Read more(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.
Read more(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:
Read more(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60.
Read more(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.
Read more(Alliance News) - GSK PLC on Tuesday said the European Commission has authorised ViiV Healthcare's "superior" drug Apretude to reduce the risk of sexually acquired HIV-1 infection.
Read more(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:
Read more(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.
Read more(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.
Read more(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.
Read more(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.
Read more(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.
Read more(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:
Read more